SIRNAOMICS
Sirnaomics is a clinical-stage biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference (RNAi) technology. The RNAi technology is used to discover and develop novel therapeutics with a focus on oncology, anti-fibrotic therapeutics, and viral infection. Its proprietary Polypeptide Nano-Particle (PNP) technology is used for small interfering RNA (siRNA) drug delivery. This technology allows accessing the tumor micro-environment (TME), as well as various cell types in the liver. Sirnaomics was founded by Patrick Y. Lu and David M. Evans in 2007 and is based in Gaithersburg, Maryland.
SIRNAOMICS
Industry:
Biopharma Biotechnology Medical Device Pharmaceutical
Founded:
2007-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.sirnaomics.com
Total Employee:
101+
Status:
Active
Contact:
+113017401730
Email Addresses:
[email protected]
Total Funding:
267 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Microsoft Exchange Online
Similar Organizations
Acacia Pharma
Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Antabio
Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Ataxion
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
Biosyntia
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Cadence Health
Cadence, a pharma startup, aims to switch a birth control pill over-the-counter to create easy and affordable access to contraceptives.
Cardiac Insight
Cardiac Insight is a privately-held medical device company that offers body-worn ECG sensing technology.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cure Pharmaceutical
Cure Pharmaceutical is a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Echo
Echo is a provider of an automated microscope intended for biological research and pathologies.
Elixiron Immunotherapeutics
Elixiron Immunotherapeutics is a company developing therapeutics for cancer, rare, and inflammatory disorders
Emerald Health Pharmaceuticals
EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Eyenovia
Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
G.I. Windows
G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
InspireMD
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
Inventiva Pharma
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.
LPATH
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.
Madrigal Pharmaceuticals
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
MATINAS BIOPHARMA
A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.
moksha8 Pharmaceuticals
Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.
NanoViricides
NanoViricides is a nano-biopharmaceutical company that develops therapeutics for patients suffering from life-threatening viral infections.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
NexImmune
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
PeriphaGen
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Samsara Therapeutics
Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.
SOFIE
SOFIE is a molecular imaging company focused on empowering people with new PET technologies.
Synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.
Umoja Biopharma
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Vaxxas
Vaxxass is a biotechnology company focused on needle-free vaccination technology.
Current Employees Featured
Founder
Investors List
Founder H Fund
Founder H Fund investment in Series E - Sirnaomics
Rotating Boulder Fund
Rotating Boulder Fund investment in Series E - Sirnaomics
Rotating Boulder Fund
Rotating Boulder Fund investment in Series D - Sirnaomics
Hongtao Capital
Hongtao Capital investment in Series D - Sirnaomics
Longmen Capital
Longmen Capital investment in Series D - Sirnaomics
Alpha Win Capital
Alpha Win Capital investment in Series D - Sirnaomics
River Head Capital
River Head Capital investment in Series D - Sirnaomics
Sangel Capital
Sangel Capital investment in Series D - Sirnaomics
Walvax Biotechnology
Walvax Biotechnology investment in Series D - Sirnaomics
Legend Sky Investment
Legend Sky Investment investment in Series C - Sirnaomics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-29 | RNAimmune | Sirnaomics investment in Series A - RNAimmune | 27 M USD |
| 2021-04-21 | RNAimmune | Sirnaomics investment in Seed Round - RNAimmune | 10 M USD |
Official Site Inspections
http://www.sirnaomics.com Semrush global rank: 7.76 M Semrush visits lastest month: 437
- Host name: 104.26.8.59
- IP address: 104.26.8.59
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sirnaomics"
Sirnaomics - Crunchbase Company Profile & Funding
Sirnaomics is a clinical-stage biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference (RNAi) technology. The RNAi technology is used to discover and develop novel …See details»
Home | Sirnaomics
Sirnaomics is the first to achieve positive Phase IIb clinical outcomes in oncology clinical-stage RNA therapeutics biopharmaceutical company with a strong presence in both China and the U.S. that is discovering and developing …See details»
About Us - Sirnaomics
Sirnaomics is the first to achieve positive Phase IIb clinical outcomes in oncology clinical-stage RNA therapeutics biopharmaceutical company with a strong presence in both Asia and the U.S. that is discovering and developing …See details»
Sirnaomics Company Profile | Management and Employees List
Sirnaomics Profile and History. Founded in 2007, based out of Gaithersburg, Maryland, Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and …See details»
Sirnaomics - Overview, News & Similar companies | ZoomInfo.com
May 19, 2024 Who is Sirnaomics. Founded in 2007, based out of Gaithersburg, Maryland, Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and develo …See details»
SIRNAOMICS - LinkedIn
Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both Asia and the United States. Based on its proprietary delivery technologies, a polypeptide ...See details»
Sirnaomics - Contacts, Employees, Board Members, Advisors
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.See details»
Sirnaomics US Company Profile - Office Locations, Competitors
Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology. It uses a proprietary discovery platform to develop therapies …See details»
Sirnaomics - Funding, Financials, Valuation & Investors - Crunchbase
Sirnaomics is registered under the ticker HKG:2257 . Sirnaomics is funded by 19 investors. Dr. Poon Hung Fai and Hong Kong Science and Technology Parks Corporation are the most …See details»
Sirnaomics: a unique, clinical-phase RNA therapeutic …
In recent years, Sirnaomics has raised $280 million across series D and E rounds and its initial public offering (IPO), enabling it to grow into an organization with 186 employees, most of whom ...See details»
Sirnaomics Ltd. Listed on Main Board of HKEX | Sirnaomics
Dec 30, 2021 Sirnaomics Ltd. (“Sirnaomics” or “Company”, together with its subsidiaries, the “Group”, stock code: 2257.HK), the RNA therapeutics biopharmaceutical company with strong …See details»
Sirnaomics and Precision NanoSystems Have Formed a …
Jun 17, 2020 Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is a Delaware corporation headquartered in …See details»
Sirnaomics Secures $105 Million in Series E Financing - PR Newswire
Jul 1, 2021 Sirnaomics Ltd., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is a Delaware corporation headquartered in …See details»
Careers - Sirnaomics
Sirnaomics offers a highly competitive employee benefits program which allows eligible employees an opportunity to care for their health and that of their eligible dependents. Join …See details»
Sirnaomics - Recent News & Activity - Crunchbase
Jul 12, 2024 Organization. Sirnaomics . Connect to CRM . Save . Go back to Sirnaomics's Signals & News . ... ACN Newswire — Sirnaomics Announces Completion of IND-Enabling …See details»
Sirnaomics Announces Successful Completion of Cohort 1 from …
Dec 5, 2023 HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, Dec. 5, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its …See details»
Research & Development - Sirnaomics
Sirnaomics has a robust pipeline of biopharmaceutical therapies built through the in-house development of innovative product candidates and novel RNAi and mRNA delivery platforms, …See details»
Press Release - Sirnaomics
Dec 15, 2021 Sirnaomics, Inc., a biopharmaceutical company engaged in discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that …See details»
Sirnaomics Receives FDA Approval of IND for Phase 1 Clinical Trial …
Jul 6, 2021 Sirnaomics Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is a Delaware corporation headquartered in …See details»
The Science of RNAi - Sirnaomics
Leveraging the body’s naturally occurring ribonucleic acid interference (RNAi) response, Sirnaomics is working to develop therapies that target key disease proteins. RNAi therapies …See details»